Max Keiser

Osborne lines pockets with profit from drunkards & drug addicts

[youtube M8dpcEnqHHc] Watch the full Keiser Report Episode 425 on Saturday! In this episode of the Keiser Report, Max Keiser and Stacy Herbert discuss the previously successful UK economy which has become addicted to gambling and spending fortunes on spread betting and so has turned to operating ponzi schemes in order to keep the appearance of economic activity. In the second half of the show, Max Keiser talks to former Scotland Yard fraud squad detective, Rowan Bosworth-Davies of Rowans-Blog.blogspot.co.uk about the evidence he gave to the Parliamentary Committee on Banking Standards that went missing and how it is that the British banking system is remarkably similar to an organized crime racket. FOLLOW Max Keiser on Twitter: http://twitter.com/maxkeiser WATCH all Keiser Report shows here: http://www.youtube.com/playlist?list=PL768A33676917AE90 (E1-E200) http://www.youtube.com/playlist?list=PLC3F29DDAA1BABFCF (E201-E400) http://www.youtube.com/playlist?list=PLPszygYHA9K2ZtV_1KphSugBB7iZqbFyz (E401-current) RT LIVE http://rt.com/on-air Subscribe to RT! http://www.youtube.com/subscription_center?add_user=RussiaToday Like us on Facebook http://www.facebook.com/RTnews Follow us on Twitter http://twitter.com/RT_com Follow us on Google+ http://plus.google.com/+RT RT (Russia Today) is a global news network broadcasting from Moscow and Washington studios. […]

FDA Approval

Third FDA Clearance for Revolutionary Simbionix Product

Third FDA Clearance for Revolutionary Simbionix Product PR Newswire CLEVELAND, March 29, 2013 CLEVELAND , March 29, 2013 /PRNewswire/ —  Simbionix USA Corporation, the world’s leading provider of medical education and simulation training, has received FDA clearance for its TEVAR (Thoracic Endovascular Aneurysm Repair) application for PROcedure Rehearsal Studio™ (PRS) . This application joins the family of PRS cleared for marketing applications for Carotid Intervention and EVAR (Endovascular Aneurysm Repair) procedures . TEVAR is an emerging treatment modality, which has been rapidly embraced by clinicians treating thoracic aortic disease […]

Mergers & Acquisitions

Clark Hill PLC And Thorp Reed & Armstrong LLP Announce Merger Agreement, Creating 300 Attorney, 12 Office Firm

Clark Hill PLC And Thorp Reed & Armstrong LLP Announce Merger Agreement, Creating 300 Attorney, 12 Office Firm PR Newswire DETROIT and PITTSBURGH, March 29, 2013 DETROIT and PITTSBURGH , March 29, 2013 /PRNewswire/ — The law and professional service firms of Clark Hill PLC and Thorp Reed & Armstrong LLP announce an agreement to merge the two firms, each with more than 100 years of history. The firms expect the merger to close in the second quarter of this year. […]

Stock Analysts

Nokia Offloads IP Assets (AAPL) (GOOG) (IDCC) (NOK)

Finnish handset manufacturer Nokia Corporation ( NOK ), has sold 125 of its patents to intellectual property (IP) investment and advisory firm, Pendrell Corporation. However, none of the firms disclosed any financial details of the deal. Most of the assets that Nokia has sold include patents for SD cards, embedded flash, flash storage and other memory technologies that are used in a wide variety of electronic devices […]

Stock Analysts

FDA Approves Biogen’s Tecfidera (ATHX) (BIIB) (NVS) (SNY)

Tecfidera, Biogen Idec’s ( BIIB ) oral multiple sclerosis treatment, gained FDA approval recently for the first-line treatment of people with relapsing forms of multiple sclerosis. Biogen intends to launch the drug shortly. Results from studies conducted with Tecfidera showed that treatment with Tecfidera led to a significant reduction in disease activity in multiple sclerosis patients. […]

Mergers & Acquisitions

ALDILA Closes Merger Agreement with Mitsubishi Rayon America

ALDILA Closes Merger Agreement with Mitsubishi Rayon America PR Newswire POWAY, Calif., March 28, 2013 POWAY, Calif. , March 28, 2013 /PRNewswire/ — ALDILA, INC. (formerly OTCQX:ALDA) announced today that Aldila has closed the merger (the “Merger”) as contemplated by the merger agreement (the “Merger Agreement”) with Mitsubishi Rayon America, Inc […]

Stock Analysts

Takeda Seeks Japanese Approval (CYTK) (LCI) (TKPYY) (UCBJF)

Takeda Pharmaceutical Company Limited ( TKPYY ) recently announced the submission of a new drug application (NDA) to the Ministry of Health, Labour and Welfare (MHLW) in Japan for its drug Takepron (lansoprazole). The company is seeking approval of a fixed-dose combination of Takepron and low-dose aspirin for treating patients suffering from peptic ulcer. […]